Background
A class action claim was filed against a leading biotech company in the United States.
The company manufactures several generic drugs used by leading pharmaceutical companies across the world.
The company has started manufacturing essential drugs and supplies for pharma companies producing the Covid-19 vaccines.
The biotech company has scaled up its operations to match the client companies’ global requirement of the chemical compound required for the coronavirus vaccine and booster dose.